Terms of Service

By downloading, installing, accessing, or using BCILattice, bcinexus.xyz, the BCINexus community, or any related cloud feature (together, the "Services"), you agree to these Terms of Service. If you use the Services on behalf of a university, company, lab, hospital, or other organization, you confirm that you have authority to accept these Terms for that organization. Hospitals, clinics, and other covered entities must also read Section 9 before using any cloud feature with patient data. Separate signed order forms, enterprise agreements, data processing agreements, or business associate agreements control where they expressly conflict with these Terms.

BCILattice is desktop research software for BCI and biosignal work, including signal import, preprocessing, visual workflow design, machine learning, experiment tracking, reporting, and model export. Signal processing and model training run on your hardware unless a separate enterprise deployment states otherwise. BCINexus cloud features are optional and may include account management, team storage, project sharing, study publishing, review workflows, billing, and support. Plan limits, storage quotas, upload types, and support levels are defined on the pricing page, checkout page, or signed order form. Recordings, projects, trained models, and other data stored only on your device are your responsibility to back up. BCINexus has no access to and cannot recover data that exists solely on your local storage and becomes lost, corrupted, or inaccessible, including from hardware failure, accidental deletion, or operating system issues. Cloud sync and backup features reduce this risk but are not a substitute for your own backup practice.

You must provide accurate account information and keep it current. You are responsible for safeguarding your login credentials and for activity under your account. You may not share a single-user account across multiple people. Team members must use their own accounts and be invited through the applicable team or workspace feature. Notify [email protected] promptly if you believe your account has been compromised.

Paid plans are billed in advance according to the billing cycle selected at checkout or specified in your order form. Available cycles may include monthly, six-month, annual, institutional invoice, or custom enterprise billing. For self-serve plans: - Monthly plans renew each month on the subscription date. - Six-month plans renew every six months at the displayed discounted rate. - Annual plans renew once per year at the displayed discounted rate. Self-serve checkout and payment processing are handled by Paddle or another disclosed payment provider. BCINexus does not store raw card numbers. Subscriptions renew automatically unless cancelled before renewal. Cancellations and downgrades take effect at the end of the current billing period unless the checkout flow, support response, payment-provider flow, or order form states otherwise. If subscription management is unavailable or unclear, contact [email protected] from the email address associated with your account. Taxes, bank fees, currency conversion charges, and procurement fees are your responsibility unless prohibited by law.

Self-serve Researcher and Lab subscriptions are covered by the Refund Policy published at bcinexus.xyz/refund. Enterprise purchases are governed by the signed order form, invoice, purchase order, or master agreement. Unless required by law or stated in a written agreement, fees are non-refundable after the applicable refund window. For billing or refund requests, contact [email protected] from the email address associated with your account.

You may use the Services for lawful research, education, development, evaluation, and commercial work permitted by your plan. You may not: - Reverse engineer, decompile, disassemble, or bypass technical restrictions except where law expressly permits it - Share account credentials or evade plan limits - Upload malware, unlawful content, or content that infringes third-party rights - Publish misleading, plagiarized, unsafe, or unsupported research claims - Process human-subject data without required consent, ethics approval, IRB approval, or equivalent institutional authorization - Use the Services in violation of export controls, sanctions, privacy law, clinical research rules, or platform security rules - Interfere with BCINexus infrastructure or attempt unauthorized access We may suspend or restrict accounts that violate these Terms, create security risk, or expose BCINexus or other users to legal or operational harm.

BCILattice, BCINexus, the website, product design, documentation, trademarks, source code, file formats, and all BCINexus and BCILattice extensions, plugins, integrations, and other proprietary platform components (collectively, "BCINexus Technology") are owned by BCINexus or its licensors and are proprietary and confidential. No rights to BCINexus Technology are granted except the limited license below. Subject to these Terms and your active plan, you receive a limited, non-exclusive, non-transferable license to use the Services. You retain ownership of datasets, experiments, trained models, reports, studies, session files, and other content you create or upload ("Your Content"). By using a BCINexus cloud feature to upload, sync, share, or publish Your Content, you grant BCINexus a worldwide, non-exclusive, royalty-free license to host, store, reproduce, process, and use Your Content to operate, secure, support, and improve the Services. Separately, where Your Content has "public" visibility — never team or private content — you additionally grant BCINexus a license to analyze usage patterns, workflows, and pipeline structures in that public content, and to use it to advance BCI research and to develop, train, fine-tune, evaluate, and improve BCINexus's AI models, AI agents, and product features. This license applies only while the content remains public and only if you have not turned it off. This setting defaults on for web-app accounts and defaults off for desktop-app accounts, and you can view or change it at any time in Settings. Content that may constitute PHI or other regulated patient data is never used for this purpose, regardless of visibility or setting, absent a signed Business Associate Agreement or equivalent covering that specific use. By publishing content to the BCINexus community, you additionally grant BCINexus and community users a non-exclusive license to host, view, download, reproduce, evaluate, and use that published content for research, review, and interoperability purposes. You must have the rights needed to upload or publish anything you submit, including any required consent, ethics, or IRB approval for human-subject data. Section 9 governs data that may constitute PHI or regulated patient data.

BCILattice may let you connect optional third-party AI providers using your own API keys or account credentials. You are responsible for reviewing provider terms, privacy settings, data-sharing behavior, and institutional approval before sending content to any external AI service. BCINexus is not responsible for outputs generated by third-party AI systems. AI outputs may be inaccurate and must be independently reviewed before being used in research decisions, publications, regulatory submissions, clinical workflows, or safety-critical work.

BCILattice is research software. It is not a medical device, diagnostic product, treatment system, emergency system, or substitute for professional clinical judgment. You are responsible for study design, consent, ethics approval, statistical validity, validation, documentation, regulatory classification, and clinical governance. Do not use the Services for diagnosis, treatment, or patient management unless you have obtained all required validation, approvals, clearances, and written agreements. If any content you upload, sync, share, or publish through a BCINexus cloud feature may constitute protected health information (PHI) or other regulated patient data, you must not use cloud upload, sync, sharing, or publishing features for that content unless BCINexus has reviewed and executed a signed Business Associate Agreement (or equivalent) covering that specific use. See the BAA and PHI Policy for details. Local, on-device processing remains governed by your own environment, approvals, and institutional controls. BCILattice's optional Participant registry and Clinical Mode are informed-consent and subject-tracking tools for IRB-approved research studies, not a clinical/EHR system and not a substitute for your institution's patient-consent processes. Enabling Clinical Mode only requires that a Participant have a consent record on file before a recording session starts — it does not verify or validate that consent was properly obtained, which remains your and your institution's responsibility. Participant identity in the app defaults to an investigator-assigned code rather than a real name; if you choose to enter a real name or upload a signed consent document, that content is subject to the PHI/BAA restriction above like any other cloud-synced content. The "Doctor" account designation is an identity/credential label only and grants no clinical authority within the Services.

The Services are provided "as is" and "as available" to the maximum extent permitted by law. BCINexus does not warrant that the Services will be uninterrupted, error-free, secure, validated for a specific protocol, or suitable for any particular research, clinical, regulatory, commercial, or publication purpose. Some jurisdictions do not allow certain warranty exclusions, so parts of this section may not apply to you.

To the maximum extent permitted by law, BCINexus will not be liable for indirect, incidental, special, consequential, exemplary, or punitive damages, including loss of data, research interruption, publication delay, lost revenue, lost profits, or failed experiments. BCINexus's total liability for all claims relating to the Services will not exceed the amount you paid to BCINexus for the Services in the 12 months before the event giving rise to the claim, unless a signed agreement states a different cap or applicable law requires otherwise.

You may stop using the Services at any time and cancel a paid subscription as described in Section 4. BCINexus may suspend or terminate your access for violating these Terms or the Acceptable Use Policy, for non-payment, to comply with law, or to protect the security or integrity of the Services, with notice where practical and without notice where immediate action is required. BCINexus may also discontinue a feature or the Services generally, with reasonable notice where practical given the circumstances. The BCILattice desktop application continues to operate for local, on-device work independent of your account status where technically applicable. For data held in BCINexus cloud features, we will provide a reasonable opportunity to export it before deletion where practical, except where immediate suspension is required for security, legal, or Acceptable Use reasons. Records retained after termination are described in the Privacy Policy and Data Retention Schedule. Sections that by their nature are meant to continue — including Intellectual Property, the Research and Clinical Disclaimer, Disclaimer of Warranties, Limitation of Liability, Indemnification, and Governing Law — survive termination.

You will defend, indemnify, and hold harmless BCINexus, its officers, employees, and licensors from claims, damages, losses, and reasonable legal costs arising from: (a) content you upload, publish, or share through the Services; (b) your violation of these Terms, the Acceptable Use Policy, or applicable law; or (c) your lack of required consent, ethics approval, or authorization for data you process through the Services. BCINexus may assume exclusive defense of a matter subject to indemnification, in which case you will cooperate with that defense.

If you have a signed order form or enterprise agreement, the governing law and dispute process in that document applies. For self-serve purchases where no separate written agreement applies, these Terms are governed by the laws of Pakistan, without regard to conflict-of-law rules. Before filing a formal claim, both parties agree to first try to resolve the dispute in good faith by contacting [email protected]. Nothing in these Terms limits non-waivable consumer, privacy, or data-protection rights that apply in your jurisdiction.

Entire agreement: These Terms, the Acceptable Use Policy, the Privacy Policy, and any signed order form are the entire agreement between you and BCINexus regarding the Services, and supersede prior discussions about the same subject matter. Severability: If a provision of these Terms is found unenforceable, the rest remain in full effect and the unenforceable provision will be read to achieve its intent as closely as the law allows. No waiver: Not enforcing a provision on one occasion does not waive our right to enforce it later. Assignment: You may not assign these Terms without our written consent. BCINexus may assign these Terms in connection with a merger, acquisition, reorganization, or sale of assets, or to an affiliate, without your consent. Force majeure: Neither party is liable for delay or failure to perform caused by events beyond its reasonable control, including outages of third-party infrastructure, natural disaster, war, or government action.

We may update these Terms to reflect product, legal, or operational changes. If changes are material, we will provide notice by email, in-app message, or website notice where required. Responsible party: BCINexus. Formal legal entity name, registered address, DPO, EU representative, and UK representative details require business/legal approval before publication. Questions about these Terms: [email protected]